High-density lipoprotein cholesterol therapies: the next frontier in lipid management.

Keywords

Medicine, Cholesterol, Coronary heart disease, Lipoprotein, High-density lipoprotein

References

• Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null MiceRoberto Toledo Palliser — 2004
• Apolipoprotein A-IMilano: current perspectivesGiulia Chiesa, Cesare R. Sirtori — 2003
• Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.AM Dattilo, PM Kris-Etherton — 1992
• Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factorsE. B. Rimm, Paige L. Williams, Kerry Fosher — 1999
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.Luc F. Van Gaal, Aila Rissanen, André Scheen — 2005
• A Randomized Trial of a Strategy for Increasing High-Density Lipoprotein Cholesterol Levels: Effects on Progression of Coronary Heart Disease and Clinical EventsEdwin J. Whitney, Richard A. Krasuski, Bradley E. Personius — 2005
• Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor.M.C. Francis, Jiří Fröhlich — 2001
• Effects of intravenous infusion of lipid-free apo A-I in humans.M. Nazeem Nanjee, John R. Crouse, James M. King — 1996
• Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia.Jan Albert Kuivenhoven, Greetje J. de Grooth, Hitoshi Kawamura — 2005
• High-density lipoproteins as an emerging therapeutic target for atherosclerosis.Daniel J. Rader — 2003
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.Bryan Brown, Xue-Qiao Zhao, Alan Chait — 2001
• The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis.Kenji Maeda, Yoshinori Noguchi, Tsuguya Fukui — 2003
• High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.Philip J. Barter, J. Kastelein, Alistair V.W. Nunn — 2003
• Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma CholesterolMohamad Navab, G.M. Anantharamaiah, Susan Hama — 2002
• Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.Lars A. Carlson, G. Rosenhamer — 2009
• Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).Xue-Qiao Zhao, Josh S. Morse, Alice Dowdy — 2004
• The endocannabinoid system and its therapeutic exploitationVincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis — 2004
• PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effectSorin Tunaru, Jukka Kero, Annette Schaub — 2003
• Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.Steven E. Nissen, Taro Tsunoda, E. Murat Tuzcu — 2003
• Effects of Endurance Exercise Training on Plasma HDL Cholesterol Levels Depend on Levels of Triglycerides: Evidence From Men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family StudyCharles Couillard, Jean‐Pierre Després, Benoı̂t Lamarche — 2001

Cited by

• Bases genéticas de la variación en los niveles plasmáticos de HDL-colesterolMaría Teresa Villarreal Molina — 2008
• Therapy and clinical trials: beyond low-density lipoprotein cholesterol reduction.Sujit Bhattacharya — 2006

Related papers

• Stimulation of esterified cholesterol accumulation in tissue culture cells exposed to high density lipoproteins enriched in free cholesterol.George H. Rothblat, L Y Arbogast, Eva Ray — 1978
• Cholesterol transfer between alpha- and beta-lipoprotein fractions in serum. Method of estimation and some factors influencing the cholesterol translocation.Shinji Nakajima, Kiyomi OZASA, Kazumasa Hada — 1988
• Clinical research of lipoprotein(a) and oxidized low-density lipoprotein level in coronary heart disease patientsZhang Shou-long — 2012
• Cholesterol-loading of peripheral tissues alters the interconversion of high density lipoprotein subfractions in rabbits.Yára Dadalti Fragoso, E. ROY SKINNER — 1996
• CORONARY HEART DISEASE; TO FIND CORRELATION AMONG TOTAL CHOLESTEROL, TRIGLYCERIDES, HIGH DEN- SITY LIPOPROTEIN CHOLESTEROL, LOW DENSITY LIPOPROTEIN CHOLESTEROL IN OFF- SPRINGS OF PARENTS HAVING CORONARY HEART DISEASE.Munir Ahmed — 2014
• Antibodies against high-density lipoprotein binding proteins enhance high-density lipoprotein uptake but do not affect cholesterol efflux from rat hepatoma cells.Dmitri Sviridov, Takayuki Sasahara, Louise E. Pyle — 1997
• Elevated high-density-lipoprotein cholesterol and normal triglycerides as markers of longevityMatti Nikkilä, T Pitkäjärvi, T. Koivula — 1991
• A potential role of cholesterol uptake capacity, a new measure for high-density lipoprotein functionality, in coronary risk stratificationA. Harada, Ryuji Toh, K. Murakami — 2016